CSPC PHARMACEUTICAL GROUP LIMITED financial statements, including revenue, expenses, and profit
The total revenue of 1093 for the last semiannual is 13.80 B HKD, and it's 21.77% lower compared to the previous semiannual. The net income of H2 24 is 1.42 B HKD.